Aug 02, 2024 / 11:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q1 FY25 earnings conference call of Eris Lifesciences Limited. We have with us on the call today are Mr. Amit Bakshi, Chairman and Managing Director; Mr. V. Krishnakumar, Chief Operating Officer and Executive Director; Mr. Sachin Shah, Chief Financial Officer, and Ms. Kruti Raval, Head, Investor Relations.
(Operator Instructions) Please note this call is being recorded. I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company.
Thank you, and over to you. Sir.
Krishnakumar Vaidyanathan - Eris Lifesciences Ltd - Chief Operating Officer, Executive Director
Good evening, everybody, and welcome to our Quarter one, conference call. So before we dive into the details, it's probably useful to take a couple of minutes to articulate how we think about our business, how the business is structured. There's been a lot of change in the last few months. And that also gives you a sense of how this presentation is organized. So we have two business
Q1 2025 Eris Lifesciences Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot